Cargando…
High density lipoproteins-based therapies for cardiovascular disease
Atherosclerosis is the leading cause of death in developed countries. High density lipoproteins (HDL) cholesterol level correlates inversely with the risk of cardiovascular diseases. Thus, HDL has obtained lots of interest for drug development. In this review, we summarized the mechanisms for the an...
Autores principales: | Gao, Xuan, Yuan, Shujun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982209/ https://www.ncbi.nlm.nih.gov/pubmed/21187875 http://dx.doi.org/10.4103/0975-3583.70898 |
Ejemplares similares
-
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
por: Estrada-Luna, Diego, et al.
Publicado: (2018) -
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
por: Kapur, Navin K, et al.
Publicado: (2008) -
Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion
por: Fisher, Eric, et al.
Publicado: (2014) -
Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013) -
High-Density Lipoproteins in Non-Cardiovascular Diseases
por: Zanotti, Ilaria
Publicado: (2022)